Fluoropolymer coated dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: A multicentre trial

ANZ Journal of Surgery

Volumn 73, Issue 3, 2003, Pages 95-99

  Robinson, Brett I ^a   Fletcher, John P ^a   Richardson, A ^b   Tomlinson, P ^b   Bell, R ^b   Fisher, C ^b   Condous, M ^b   Ventura, R ^b   Scott, A ^b   Stary, D ^b   Allen, R ^b   Lippey, E ^b   Appleberg, M ^b   Chao, A ^b   Fitridge, R ^b   Frydman, G ^b   Hazelton, S ^b   King, B ^b   Middleton, P ^b   Pai, P ^b   Thomson, I ^b   Beiles, B ^b   Gray Wheale, A ^b   Lane, R ^b   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

Femoropopliteal bypass; Polytetrafluoroethylene; Prosthetic graft

Indexed keywords

DACRON; FLUOROPOLYMER; POLITEF; POLYMER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLAUDICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEMOROPOPLITEAL BYPASS; GRAFT PATENCY; GRAFT SURVIVAL; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE; THROMBECTOMY; THROMBOSIS; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FEMORAL ARTERY; FLUOROCARBON POLYMERS; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LEG; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYETHYLENE TEREPHTHALATES; POLYTETRAFLUOROETHYLENE; POPLITEAL ARTERY; PROSPECTIVE STUDIES; VASCULAR PATENCY;

EID: 0037366542     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2003.02653.x     Document Type: Article

References (25)

1. Veith FJ, Gupta SK, Ascer E et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J. Vasc. Surg. 1986; 3: 104-14.
2. Londrey GL, Ramsey DE, Hodgson KJ, Barkmeier LD, Sumner DS. Infrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts. J. Vasc. Surg. 1991; 13: 631-6.
3. Chang JB, Stein TA. The long-term value of composite grafts for limb salvage. J. Vasc. Surg. 1995; 22: 25-31.
4. Archie JP Jr. Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. Ann. Vasc. Surg. 1994; 8: 475-84.
5. Hunik MG, Wong JB, Donaldson MC et al. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med. Decis. Making 1994; 14: 71-81.
6. Donaldson MC, Mannick JA, Whittemore AD. Femoro-distal bypass with in situ greater saphenous vein. Ann. Surg. 1991; 213: 457-65.
7. Wilson YG, Wyatt MG, Currie JC, Baird RN, Lamont PM. Preferential use of vein for above-knee femoropopliteal grafts. Eur. J. Vasc Surg. 1995; 10: 220-5.
8. Moore WS, Quinones-Baldrich WJ. An argument against all autogenous tissue for vascular bypasses below the inguinal ligament. Adv. Surg. 1991; 24: 91-101.
9. Patterson RB, Fowl RJ, Kempczinski RF et al. Preferential use of ePTFE for above-knee femoropopliteal bypass grafts. Ann. Vasc. Surg. 1990; 4: 338-43.
10. McCollum CN, Kenchington G, Alexander C, Franks P, Greenhalgh RM and the Femoropopliteal Bypass Trial Participants. PTFE of HUV for femoropopliteal bypass: a multicentre trial. Eur. J. Vasc Surg. 1991; 5: 435-43.
11. Burger DH, Kappetein AP, Hajo van Bockel J, Breslau PJ. A prospective randomized trial comparing vein with polytetrafluoroethylene in above knee femoropopliteal bypass grafting. J. Vasc. Surg. 2000; 32: 278-83.
12. Johnson WJ, Lee KK and members of the Department of Veteran Affairs COOP Study. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoropopliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J. Vasc. Surg. 2000; 32: 268-77.
13. Rosenthal D, Evans RD, McKinsey J et al. Prosthetic above-knee femoropopliteal bypass for intermittent claudication. J. Cardiovasc. Surg. 1990; 31: 462-8.
14. Pevec WC, Darling RC, L'Italien GJ et al. Femoropopliteal reconstruction with knitted, non-velour Dacron versus expanded polytetrafluoroethylene. J. Vasc. Surg. 1992; 16: 60-5.
15. Abbott WM, Green RM, Matsumoto T et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. J. Vasc. Surg. 1997; 25: 19-28.
16. Green RM, Abbott WM, Matsumoto T et al. Prosthetic above-knee femoropopliteal bypass grafting: Five-year results of a randomized trial. J. Vasc. Surg. 2000; 31: 417-25.
17. Robinson BI, Fletcher JPP, Tomlinson P et al. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass. Cardiovasc. Surg. 1999; 7: 214-8.
18. Devine C, McCollum C and the North West femoro-popliteal trial participants. Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. J. Vasc. Surg. 2001; 33: 533-9.
19. Post S, Kraus T, Muller-Reinartz U et al. Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomized multicentre trial. Eur. J. Vasc. Endovasc. Surg. 2001; 22: 226-31.
20. Rutherford RB, Baker JD, Calvin E et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J. Vasc. Surg. 1997; 26: 517-37.
21. El-Masry S, Saad E, Sauvage LR et al. Femoropopliteal bypass with externally supported knitted Dacron grafts: a follow-up of 200 grafts for one to twelve years. J. Vasc. Surg. 1994; 19: 487-94.
22. Prendiville EJ, Yeager A, O'Donnell TF et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J. Vasc. Surg. 1990; 11: 517-24.
23. Cenni E, Ciapetti G, Cervellati M et al. Activation of the plasma coagulation system induced by some biomaterials. J. Biomed. Mater. Res. 1996; 31: 145-8.
24. Cenni E, Granchi D, Verri E et al. CD62, thromboxane B2, and beta-thromboglobulin: a comparison between different markers of platelet activation after contact with biomaterials. J. Biomed. Mater. Res. 1997; 36: 289-94.
25. Ao PY, Hawthorne WJ, Vicaretti M, Fletcher JP. Development of intimal hyperplasia in six different vascular prostheses. Eur J. Vasc. Endovasc. Surg. 2000; 20: 241-9.